Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis (Nature, (2018), 560, 7717, (192-197), 10.1038/s41586-018-0356-z)

Susan Wyllie, Michael Thomas, Stephen Patterson, Sabrinia Crouch, Manu De Rycker, Rhiannon Lowe, Stephanie Gresham, Michael D. Urbaniak, Thomas D. Otto, Laste Stojanovski, Frederick R.C. Simeons, Sujatha Manthri, Lorna M. MacLean, Fabio Zuccotto, Nadine Homeyer, Hannah Pflaumer, Markus Boesche, Lalitha Sastry, Paul Connolly, Sebastian AlbrechtMatt Berriman, Gerard Drewes, David W. Gray, Sonja Ghidelli-Disse, Susan Dixon, Jose M. Fiandor, Paul G. Wyatt, Michael A.J. Ferguson, Alan H. Fairlamb, Timothy J. Miles (Lead / Corresponding author), Kevin D. Read (Lead / Corresponding author), Ian H. Gilbert (Lead / Corresponding author)

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Nature Published online 25 July 2018 During the publication process, the authors mistakenly included the wrong image for Fig. 3c. The correct Fig. 3c is shown as Fig. 1 below. The error is in presentation and makes no material difference to the scientific conclusions. The values shown in the legend for Fig. 3c and in the supporting information (Table S8) remain correct. We would like to acknowledge the anonymous scientist who pointed out the error. (Figure presented.) .

Original languageEnglish
Pages (from-to)E48
Number of pages1
JournalNature
Volume619
DOIs
Publication statusPublished - 4 Jul 2023

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis (Nature, (2018), 560, 7717, (192-197), 10.1038/s41586-018-0356-z)'. Together they form a unique fingerprint.

Cite this